TRIM33 and dermatomyositis: Other studies suggest that when DM occurs, large amounts of TIF-1γ in the skin and muscle produce significant quantities of antibodies that impact intracellular metabolism through interactions with EMT, β-linked proteins, and mitotic processes [5, 33, 34].